A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

Clinical trial NCT06975748 · RECRUITING

Trial details

NCT number: NCT06975748
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neurotrophic Keratitis

Start date: 2025-06-12
Primary completion: 2026-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.